Clinical Trial Studying the Efficacy and Safety of IP2018 in Depressed, Erectile Dysfunction (ED) Patients

NCT04686916 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Erectile Dysfunction

Interventions

DRUG: IP2018
DRUG: Placebo

Sponsor

Initiator Pharma